| First human case description of TandemHeart-assisted high-risk percutaneous balloon aortic valvuloplasty using bivalirudin anticoagulation. | |
| | |
MedLine Citation:
|
PMID: 17297193 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
TandemHeart is a recently-introduced percutaneous left ventricular assist device that can be used for hemodynamic support during high-risk interventional procedures in severely compromised patients. Angioplasty and stent placement in patients with coronary artery disease and high-risk coronary anatomy including the left main coronary artery have been described using this device. We report the first human case description of a high-risk percutaneous balloon aortic valvuloplasty for critical bicuspid aortic stenosis using the TandemHeart for periprocedural hemodynamic support. Also not previously reported is the use of bivaluridin as the periprocedural antithrombin agent during and after high-risk aortic valvuloplasty. |
| | |
Authors:
|
Sanjay Rajdev; William B Hillegass; Vijay Misra |
Related Documents
:
|
7328223 - Spontaneous rupture of an intra-aortic balloon pump. 11948373 - Molecular strategy using cis-element 'decoy' of e2f binding site inhibits neointimal fo... 15808753 - Stent underexpansion and residual reference segment stenosis are related to stent throm... |
Publication Detail:
|
Type: Case Reports; Journal Article; Review |
Journal Detail:
|
Title: The Journal of invasive cardiology Volume: 19 ISSN: 1557-2501 ISO Abbreviation: J Invasive Cardiol Publication Date: 2007 Jan |
Date Detail:
|
Created Date: 2007-02-13 Completed Date: 2007-03-06 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8917477 Medline TA: J Invasive Cardiol Country: United States |
Other Details:
|
Languages: eng Pagination: E5-8 Citation Subset: IM |
Affiliation:
|
University of Alabama at Birmingham, Birmingham, AL 35205, USA. sanjayrajdev@hotmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Balloon
/
methods* Anticoagulants / therapeutic use Aortic Valve Stenosis / therapy*, ultrasonography Echocardiography, Transesophageal Follow-Up Studies Heart Catheterization Heart-Assist Devices* Hirudins Humans Intra-Aortic Balloon Pumping / methods Male Middle Aged Peptide Fragments / therapeutic use* Recombinant Proteins / therapeutic use Risk Assessment Severity of Illness Index Stroke Volume Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants; 0/Hirudins; 0/Peptide Fragments; 0/Recombinant Proteins; 128270-60-0/bivalirudin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Use of monorail PTCA balloon catheter for local drug delivery.
Next Document: Paediatric adverse drug reaction reporting: understanding and future directions.